URSOSIOL

URSOSIOL was reported 19983 times

URSOSIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CFTR GENE MUTATION 19 0.7600
1 CYTOMEGALOVIRUS URINARY TRACT INFECTION 13 0.4194
2 TONIC POSTURING 14 0.2295
3 BILE ACIDS INCREASED 39 0.2203
4 RESPIRATORY TRACT MALFORMATION 28 0.2105
5 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 15 0.1562
6 PULMONARY MALFORMATION 42 0.1197
7 BILIARY CIRRHOSIS 21 0.1045
8 HAEMOSIDEROSIS 24 0.0896
9 BLOOD ALKALINE PHOSPHATASE ABNORMAL 77 0.0856
10 VENOOCCLUSIVE DISEASE 188 0.0750
11 CHOLESTASIS OF PREGNANCY 34 0.0739
12 PRIMARY BILIARY CHOLANGITIS 34 0.0723
13 LUNG CYST 27 0.0687
14 PARENTERAL NUTRITION 15 0.0649
15 VENOOCCLUSIVE LIVER DISEASE 279 0.0564
16 BILIARY CIRRHOSIS PRIMARY 18 0.0520
17 DEVICE RELATED BACTERAEMIA 15 0.0484
18 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 43 0.0482
19 CHOLANGITIS SCLEROSING 96 0.0467
20 VANISHING BILE DUCT SYNDROME 51 0.0457
21 LACTATION DISORDER 22 0.0451
22 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 238 0.0437
23 APLASTIC ANAEMIA 225 0.0430
24 POOR SUCKING REFLEX 17 0.0428
25 PORTAL HYPERTENSIVE GASTROPATHY 24 0.0426
26 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 25 0.0415
27 COMPLICATIONS OF TRANSPLANTED LIVER 14 0.0388
28 DISSEMINATED ASPERGILLOSIS 18 0.0381
29 BILE DUCT STENOSIS 43 0.0359
30 BILIARY TRACT INFECTION 22 0.0354
31 RED BLOOD CELL TRANSFUSION 14 0.0341
32 ASPARTATE AMINOTRANSFERASE ABNORMAL 48 0.0315
33 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 77 0.0278
34 ENTEROCOCCAL SEPSIS 22 0.0272
35 GRAFT VERSUS HOST DISEASE IN LIVER 19 0.0265
36 HYPERTONIA NEONATAL 14 0.0262
37 CYSTIC FIBROSIS 145 0.0262
38 LIP PRURITUS 22 0.0257
39 RENAL ISCHAEMIA 14 0.0256
40 PORTAL HYPERTENSION 79 0.0256
41 ACUTE GRAFT VERSUS HOST DISEASE 117 0.0255
42 HEPATORENAL SYNDROME 43 0.0255
43 CHOLANGITIS ACUTE 19 0.0252
44 OESOPHAGEAL ACHALASIA 16 0.0248
45 PANCREATITIS RELAPSING 20 0.0244
46 PSEUDOMONAS TEST POSITIVE 20 0.0244
47 IRON OVERLOAD 26 0.0241
48 LIVER TRANSPLANT 86 0.0236
49 ALLERGIC SINUSITIS 20 0.0233
50 VARICES OESOPHAGEAL 68 0.0225
51 LIVER TRANSPLANT REJECTION 40 0.0222
52 CHOLANGITIS 138 0.0222
53 HEPATIC FIBROSIS 74 0.0215
54 GLOMERULOSCLEROSIS 13 0.0206
55 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 29 0.0205
56 CHOLANGIOCARCINOMA 30 0.0201
57 GRAFT VERSUS HOST DISEASE 134 0.0186
58 POUCHITIS 15 0.0174
59 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 37 0.0174
60 AXONAL NEUROPATHY 15 0.0172
61 BILE DUCT STONE 52 0.0163
62 ALANINE AMINOTRANSFERASE ABNORMAL 34 0.0161
63 VASCULAR DEVICE INFECTION 73 0.0161
64 CHRONIC GRAFT VERSUS HOST DISEASE 58 0.0160
65 KLEBSIELLA BACTERAEMIA 15 0.0158
66 HEPATIC INFECTION 20 0.0157
67 METASTASES TO SKIN 16 0.0155
68 BILIARY TRACT DISORDER 21 0.0152
69 CYTOMEGALOVIRUS TEST POSITIVE 26 0.0146
70 BILIRUBIN CONJUGATED INCREASED 34 0.0145
71 GRAFT VERSUS HOST DISEASE IN SKIN 32 0.0145
72 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 37 0.0143
73 PLATELET TRANSFUSION 18 0.0140
74 GALLBLADDER ENLARGEMENT 15 0.0139
75 BILIARY OBSTRUCTION 18 0.0139
76 PULMONARY FUNCTION TEST DECREASED 58 0.0132
77 ESCHERICHIA BACTERAEMIA 30 0.0127
78 BLOOD BILIRUBIN ABNORMAL 16 0.0125
79 BLOOD BILIRUBIN INCREASED 334 0.0124
80 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 16 0.0121
81 STEROID DIABETES 18 0.0120
82 EPSTEIN-BARR VIRAEMIA 13 0.0117
83 HEPATIC ENCEPHALOPATHY 109 0.0117
84 MUCOSAL INFLAMMATION 305 0.0116
85 BLOOD ALKALINE PHOSPHATASE INCREASED 289 0.0116
86 EXPOSURE VIA BREAST MILK 46 0.0115
87 OESOPHAGEAL VARICES HAEMORRHAGE 25 0.0115
88 HEPATIC PAIN 49 0.0115
89 HYPERBILIRUBINAEMIA 117 0.0113
90 IMMUNE-MEDIATED HEPATIC DISORDER 22 0.0113
91 MATERNAL EXPOSURE DURING BREAST FEEDING 45 0.0111
92 BONE MARROW TRANSPLANT 21 0.0111
93 HEPATIC CIRRHOSIS 204 0.0108
94 PNEUMONIA CYTOMEGALOVIRAL 21 0.0108
95 ADENOVIRUS INFECTION 31 0.0107
96 CAPILLARY LEAK SYNDROME 22 0.0106
97 CYTOMEGALOVIRUS INFECTION REACTIVATION 47 0.0106
98 GASTROENTERITIS NOROVIRUS 14 0.0105
99 PRE-ECLAMPSIA 50 0.0105
100 LIVER ABSCESS 34 0.0105
101 BLOOD LOSS ANAEMIA 23 0.0101
102 IMMUNE-MEDIATED HEPATITIS 20 0.0098
103 SPUTUM INCREASED 21 0.0097
104 ASCITES 282 0.0096
105 BILIARY DILATATION 14 0.0095
106 AUTOIMMUNE HEPATITIS 66 0.0095
107 ACUTE MYELOID LEUKAEMIA RECURRENT 20 0.0093
108 CHOLESTASIS 178 0.0093
109 HEPATITIS TOXIC 24 0.0092
110 PARAINFLUENZAE VIRUS INFECTION 14 0.0092
111 HEPATIC FAILURE 273 0.0090
112 BILE DUCT OBSTRUCTION 17 0.0090
113 INTRA-ABDOMINAL FLUID COLLECTION 16 0.0089
114 HEPATIC MASS 17 0.0088
115 KIDNEY FIBROSIS 15 0.0086
116 NORMAL NEWBORN 47 0.0086
117 AMMONIA INCREASED 44 0.0086
118 HEPATOSPLENOMEGALY 22 0.0086
119 CHOLESTATIC LIVER INJURY 19 0.0085
120 JAUNDICE CHOLESTATIC 30 0.0085
121 STEM CELL TRANSPLANT 21 0.0084
122 HYPERPHOSPHATAEMIA 18 0.0084
123 PORTAL VEIN THROMBOSIS 27 0.0083
124 HYPOALBUMINAEMIA 62 0.0080
125 HEPATIC NECROSIS 30 0.0080
126 CYSTITIS HAEMORRHAGIC 32 0.0079
127 HUMAN HERPESVIRUS 6 INFECTION 15 0.0079
128 POLYMYOSITIS 14 0.0079
129 MULTIPLE ORGAN DYSFUNCTION SYNDROME 223 0.0079
130 OCULAR ICTERUS 34 0.0078
131 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
132 BK VIRUS INFECTION 26 0.0077
133 LUNG TRANSPLANT 27 0.0076
134 PNEUMONIA KLEBSIELLA 14 0.0076
135 PNEUMONIA STAPHYLOCOCCAL 15 0.0076
136 JAUNDICE 200 0.0074
137 FORCED EXPIRATORY VOLUME DECREASED 21 0.0074
138 GAMMA-GLUTAMYLTRANSFERASE INCREASED 164 0.0074
139 CYTOKINE RELEASE SYNDROME 146 0.0073
140 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 24 0.0073
141 FAECAL CALPROTECTIN INCREASED 23 0.0073
142 HEPATOMEGALY 71 0.0072
143 CYTOMEGALOVIRUS VIRAEMIA 32 0.0072
144 PROCTITIS 20 0.0071
145 STAPHYLOCOCCAL SEPSIS 35 0.0071
146 ACUTE LYMPHOCYTIC LEUKAEMIA 20 0.0071
147 HEPATIC ENZYME ABNORMAL 35 0.0070
148 DEVICE RELATED SEPSIS 14 0.0069
149 TRANSPLANT FAILURE 17 0.0069
150 PSEUDOMONAS INFECTION 59 0.0069
151 HYPERURICAEMIA 28 0.0068
152 PANCREATIC CYST 13 0.0068
153 GASTROINTESTINAL ULCER 15 0.0068
154 PNEUMONIA FUNGAL 26 0.0066
155 BACTERAEMIA 78 0.0066
156 LIVER DISORDER 286 0.0064
157 SPLENOMEGALY 75 0.0064
158 THROMBOTIC MICROANGIOPATHY 62 0.0064
159 ABDOMINAL MASS 17 0.0063
160 DRUG-INDUCED LIVER INJURY 199 0.0063
161 SERUM FERRITIN INCREASED 33 0.0063
162 ASPERGILLUS INFECTION 41 0.0062
163 PHYSICAL DECONDITIONING 16 0.0062
164 ENTEROCOCCAL INFECTION 30 0.0062
165 HEPATIC CYTOLYSIS 79 0.0062
166 STAPHYLOCOCCUS TEST POSITIVE 13 0.0062
167 HEPATIC NEOPLASM MALIGNANT 13 0.0061
168 HAEMATOLOGICAL INFECTION 15 0.0061
169 ASPARTATE AMINOTRANSFERASE INCREASED 321 0.0060
170 CHOLECYSTITIS ACUTE 34 0.0060
171 FEBRILE NEUTROPENIA 398 0.0060
172 IMMUNE-MEDIATED ENTEROCOLITIS 22 0.0060
173 STAPHYLOCOCCAL BACTERAEMIA 26 0.0060
174 SYSTEMIC CANDIDA 15 0.0060
175 PNEUMONIA VIRAL 19 0.0060
176 RENAL TUBULAR ACIDOSIS 13 0.0060
177 BLOOD ALBUMIN DECREASED 47 0.0059
178 TRANSFUSION 62 0.0059
179 FAECES PALE 13 0.0058
180 CYTOMEGALOVIRUS INFECTION 97 0.0058
181 ALANINE AMINOTRANSFERASE INCREASED 358 0.0058
182 CYTOPENIA 70 0.0057
183 BLOOD CULTURE POSITIVE 17 0.0057
184 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 54 0.0057
185 CYTOMEGALOVIRUS COLITIS 13 0.0056
186 ORGANISING PNEUMONIA 28 0.0056
187 STEATORRHOEA 15 0.0056
188 NOCARDIOSIS 14 0.0055
189 RHINOVIRUS INFECTION 21 0.0054
190 IRON DEFICIENCY 24 0.0053
191 HEPATITIS CHOLESTATIC 32 0.0053
192 HEPATIC FUNCTION ABNORMAL 197 0.0053
193 HYPERVOLAEMIA 26 0.0053
194 HEPATOCELLULAR CARCINOMA 40 0.0053
195 DISSEMINATED INTRAVASCULAR COAGULATION 74 0.0053
196 LIVER FUNCTION TEST INCREASED 111 0.0052
197 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
198 HAEMOLYSIS 39 0.0050
199 LOW BIRTH WEIGHT BABY 40 0.0050
200 SEPTIC SHOCK 218 0.0050
201 HYPERAMMONAEMIA 25 0.0050
202 IRON DEFICIENCY ANAEMIA 46 0.0050
203 PREMATURE DELIVERY 79 0.0050
204 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 29 0.0049
205 PULMONARY HAEMORRHAGE 38 0.0049
206 ENTERITIS 31 0.0048
207 PROCTALGIA 31 0.0048
208 PREMATURE BABY 144 0.0048
209 PNEUMOCYSTIS JIROVECII PNEUMONIA 48 0.0048
210 B-CELL LYMPHOMA 16 0.0047
211 INTRACRANIAL PRESSURE INCREASED 26 0.0047
212 BRONCHOPULMONARY ASPERGILLOSIS 36 0.0046
213 ESCHERICHIA INFECTION 38 0.0046
214 FIBROSIS 14 0.0045
215 TRANSAMINASES INCREASED 101 0.0045
216 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34 0.0045
217 ABNORMAL FAECES 37 0.0045
218 ACUTE RESPIRATORY DISTRESS SYNDROME 79 0.0045
219 CARDIAC FAILURE CHRONIC 19 0.0045
220 FOETAL GROWTH RESTRICTION 27 0.0044
221 BLOOD MAGNESIUM DECREASED 38 0.0044
222 CHOLELITHIASIS 144 0.0044
223 NON-SMALL CELL LUNG CANCER 21 0.0044
224 MALNUTRITION 49 0.0044
225 AUTOIMMUNE HAEMOLYTIC ANAEMIA 15 0.0044
226 DRUG LEVEL BELOW THERAPEUTIC 24 0.0043
227 BRONCHIOLITIS 15 0.0043
228 RESPIRATORY SYNCYTIAL VIRUS INFECTION 37 0.0042
229 DIASTOLIC DYSFUNCTION 13 0.0042
230 HYPOMAGNESAEMIA 58 0.0042
231 HEPATITIS ACUTE 27 0.0042
232 VITAMIN D DEFICIENCY 40 0.0041
233 NEPHROGENIC ANAEMIA 19 0.0041
234 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
235 DRUG LEVEL DECREASED 41 0.0040
236 HEPATITIS 103 0.0040
237 SKIN PAPILLOMA 16 0.0040
238 PNEUMONIA BACTERIAL 36 0.0039
239 PANCREATITIS ACUTE 88 0.0039
240 POST-TRAUMATIC STRESS DISORDER 26 0.0039
241 APHTHOUS ULCER 30 0.0039
242 SCLERODERMA 14 0.0038
243 BLOOD LACTATE DEHYDROGENASE INCREASED 61 0.0038
244 BLOOD PHOSPHORUS DECREASED 14 0.0038
245 HYPERNATRAEMIA 19 0.0038
246 PLATELET COUNT ABNORMAL 23 0.0038
247 HYPOPHOSPHATAEMIA 28 0.0038
248 APLASIA PURE RED CELL 13 0.0038
249 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
250 KLEBSIELLA INFECTION 19 0.0038
251 AZOTAEMIA 15 0.0038
252 HEPATIC ENZYME INCREASED 256 0.0038
253 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19 0.0037
254 ATELECTASIS 36 0.0037
255 RHINITIS 30 0.0037
256 FAECES SOFT 27 0.0037
257 GASTROINTESTINAL INFLAMMATION 29 0.0037
258 INSURANCE ISSUE 56 0.0037
259 ENTEROCOLITIS 21 0.0036
260 FOOD ALLERGY 28 0.0036
261 ACUTE MYELOID LEUKAEMIA 56 0.0036
262 BACTERIAL INFECTION 67 0.0036
263 PERICARDIAL EFFUSION 83 0.0036
264 COMPRESSION FRACTURE 19 0.0035
265 PANCYTOPENIA 196 0.0035
266 COAGULOPATHY 58 0.0035
267 HEPATOTOXICITY 77 0.0035
268 CARDIAC FAILURE ACUTE 23 0.0034
269 HYPERTRIGLYCERIDAEMIA 20 0.0034
270 SEPSIS 381 0.0034
271 WRONG PRODUCT ADMINISTERED 23 0.0034
272 TRANSPLANT REJECTION 27 0.0034
273 FREQUENT BOWEL MOVEMENTS 91 0.0034
274 COLECTOMY 19 0.0034
275 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 17 0.0034
276 GASTROINTESTINAL INFECTION 30 0.0033
277 PRURITUS 1283 0.0033
278 EPIGASTRIC DISCOMFORT 13 0.0033
279 ACUTE RESPIRATORY FAILURE 64 0.0033
280 SUSPECTED OFF LABEL USE 15 0.0033
281 SHOCK HAEMORRHAGIC 27 0.0033
282 CACHEXIA 17 0.0033
283 NEPHROPATHY TOXIC 37 0.0033
284 DISEASE COMPLICATION 15 0.0033
285 HAEMORRHOIDAL HAEMORRHAGE 16 0.0033
286 CHOLECYSTITIS 39 0.0033
287 BOWEL MOVEMENT IRREGULARITY 25 0.0033
288 CLOSTRIDIUM DIFFICILE INFECTION 71 0.0032
289 SMALL INTESTINAL OBSTRUCTION 40 0.0032
290 PARTIAL SEIZURES 17 0.0032
291 LOCALISED OEDEMA 15 0.0032
292 ENCEPHALOPATHY 79 0.0032
293 ADRENAL INSUFFICIENCY 39 0.0032
294 PLEURAL EFFUSION 195 0.0032
295 YELLOW SKIN 15 0.0032
296 IMMUNOSUPPRESSION 28 0.0032
297 ARTHRITIS BACTERIAL 13 0.0032
298 GASTROENTERITIS 46 0.0031
299 GESTATIONAL DIABETES 15 0.0031
300 RIGHT VENTRICULAR FAILURE 22 0.0031
301 DUODENAL ULCER 22 0.0031
302 NEUTROPHIL COUNT DECREASED 127 0.0031
303 PULMONARY TOXICITY 22 0.0031
304 HYPOXIA 109 0.0031
305 RESPIRATORY FAILURE 225 0.0031
306 HYDRONEPHROSIS 23 0.0031
307 TUMOUR LYSIS SYNDROME 27 0.0031
308 PLATELET COUNT DECREASED 327 0.0031
309 THROMBOCYTOPENIA 341 0.0030
310 SUBARACHNOID HAEMORRHAGE 31 0.0030
311 HYPOTHYROIDISM 97 0.0030
312 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0030
313 MATERNAL EXPOSURE DURING PREGNANCY 268 0.0030
314 HEPATIC LESION 13 0.0030
315 LYMPHOCYTE COUNT DECREASED 53 0.0030
316 ATRIAL SEPTAL DEFECT 25 0.0030
317 CHROMATURIA 67 0.0030
318 TACHYPNOEA 40 0.0029
319 ACUTE HEPATIC FAILURE 40 0.0029
320 DEVICE RELATED INFECTION 45 0.0029
321 PRODUCT DISTRIBUTION ISSUE 27 0.0029
322 COLITIS ULCERATIVE 130 0.0029
323 AGRANULOCYTOSIS 54 0.0029
324 MULTI-ORGAN FAILURE 50 0.0029
325 HYPERTRANSAMINASAEMIA 20 0.0029
326 MAJOR DEPRESSION 21 0.0029
327 BLOOD UREA INCREASED 48 0.0029
328 INFUSION SITE ERYTHEMA 24 0.0028
329 PREMATURE LABOUR 16 0.0028
330 INTERSTITIAL LUNG DISEASE 137 0.0028
331 HEPATITIS B 17 0.0028
332 BRONCHIECTASIS 19 0.0028
333 ACUTE KIDNEY INJURY 431 0.0028
334 CHOLECYSTECTOMY 32 0.0028
335 GALLBLADDER DISORDER 50 0.0028
336 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
337 MYOSITIS 25 0.0028
338 HYPOKALAEMIA 128 0.0028
339 CHEILITIS 15 0.0028
340 RENAL CYST 22 0.0028
341 AUTOIMMUNE DISORDER 27 0.0028
342 ENCEPHALITIS 19 0.0027
343 URINE OUTPUT DECREASED 24 0.0027
344 HEPATIC STEATOSIS 51 0.0027
345 LIVER INJURY 67 0.0027
346 LIVER FUNCTION TEST ABNORMAL 79 0.0027
347 FAILURE TO THRIVE 14 0.0027
348 MALABSORPTION 14 0.0027
349 FLUID OVERLOAD 39 0.0027
350 WEIGHT FLUCTUATION 28 0.0027
351 PULMONARY ALVEOLAR HAEMORRHAGE 15 0.0027
352 FLANK PAIN 25 0.0027
353 WHITE BLOOD CELL COUNT ABNORMAL 17 0.0027
354 SCRATCH 28 0.0027
355 FOETAL EXPOSURE DURING PREGNANCY 213 0.0026
356 ABDOMINAL TENDERNESS 13 0.0026
357 RESPIRATORY DISTRESS 72 0.0026
358 STAPHYLOCOCCAL INFECTION 86 0.0026
359 LARGE INTESTINE POLYP 18 0.0026
360 GENERALISED OEDEMA 32 0.0026
361 FAECES DISCOLOURED 56 0.0026
362 HYPERGLYCAEMIA 94 0.0026
363 ILEUS 32 0.0026
364 THERAPY INTERRUPTED 184 0.0026
365 DIARRHOEA HAEMORRHAGIC 24 0.0026
366 HAEMATEMESIS 65 0.0026
367 OESOPHAGITIS 28 0.0026
368 UPPER GASTROINTESTINAL HAEMORRHAGE 43 0.0026
369 CHOLECYSTITIS CHRONIC 17 0.0025
370 PHLEBITIS 13 0.0025
371 GASTRIC ULCER 48 0.0025
372 STOMATITIS 153 0.0025
373 MELAENA 55 0.0025
374 ELECTROLYTE IMBALANCE 29 0.0025
375 THERAPY CESSATION 128 0.0025
376 TYPE 1 DIABETES MELLITUS 15 0.0025
377 MENTAL STATUS CHANGES 69 0.0025
378 HYPOCALCAEMIA 47 0.0025
379 HAEMOPTYSIS 69 0.0025
380 BLOOD POTASSIUM INCREASED 40 0.0025
381 APPENDICITIS 23 0.0025
382 MOUTH HAEMORRHAGE 18 0.0025
383 PYREXIA 847 0.0024
384 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 25 0.0024
385 SKIN ATROPHY 14 0.0024
386 PYELONEPHRITIS 21 0.0024
387 BLOOD TEST ABNORMAL 34 0.0024
388 OLIGURIA 15 0.0024
389 EXPOSURE DURING PREGNANCY 150 0.0024
390 RALES 14 0.0024
391 THERAPY NON-RESPONDER 108 0.0024
392 ABDOMINAL DISTENSION 250 0.0024
393 TRICUSPID VALVE INCOMPETENCE 19 0.0024
394 MITRAL VALVE INCOMPETENCE 27 0.0024
395 COVID-19 PNEUMONIA 28 0.0024
396 POSTOPERATIVE WOUND INFECTION 16 0.0024
397 FULL BLOOD COUNT ABNORMAL 25 0.0024
398 PULMONARY HYPERTENSION 49 0.0024
399 PRODUCT PRESCRIBING ERROR 56 0.0023
400 MATERNAL DRUGS AFFECTING FOETUS 18 0.0023
401 TUBULOINTERSTITIAL NEPHRITIS 44 0.0023
402 PULMONARY ARTERIAL HYPERTENSION 34 0.0023
403 NEUROTOXICITY 41 0.0023
404 HAEMOGLOBIN ABNORMAL 15 0.0023
405 SINUS TACHYCARDIA 33 0.0023
406 CAESAREAN SECTION 27 0.0023
407 TASTE DISORDER 47 0.0023
408 DRUG ERUPTION 41 0.0023
409 INGUINAL HERNIA 14 0.0023
410 DERMATITIS ACNEIFORM 14 0.0023
411 ABDOMINAL PAIN 533 0.0023
412 BLOOD IRON DECREASED 27 0.0023
413 MYOCARDITIS 26 0.0023
414 PURPURA 20 0.0023
415 ANAEMIA 430 0.0023
416 BLOOD URIC ACID INCREASED 13 0.0022
417 END STAGE RENAL DISEASE 41 0.0022
418 RENAL TUBULAR NECROSIS 22 0.0022
419 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
420 NEUTROPENIA 302 0.0022
421 RENAL FAILURE 294 0.0022
422 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 121 0.0022
423 VIRAL INFECTION 73 0.0022
424 PNEUMONIA 710 0.0022
425 PRODUCT ADMINISTRATION ERROR 44 0.0022
426 RESPIRATION ABNORMAL 15 0.0022
427 PROTHROMBIN TIME PROLONGED 13 0.0022
428 LOWER GASTROINTESTINAL HAEMORRHAGE 16 0.0022
429 EOSINOPHIL COUNT INCREASED 18 0.0022
430 HERPES SIMPLEX 14 0.0022
431 PNEUMOTHORAX 34 0.0021
432 INFECTION 310 0.0021
433 POLYP 14 0.0021
434 INABILITY TO AFFORD MEDICATION 21 0.0021
435 PETECHIAE 22 0.0021
436 INTERNAL HAEMORRHAGE 24 0.0021
437 RED BLOOD CELL COUNT DECREASED 60 0.0021
438 INTESTINAL OBSTRUCTION 79 0.0021
439 OFF LABEL USE 1828 0.0021
440 CANDIDA INFECTION 35 0.0021
441 HOSPITALISATION 318 0.0021
442 CEREBRAL HAEMORRHAGE 74 0.0021
443 INFUSION SITE SWELLING 13 0.0021
444 DRUG LEVEL INCREASED 34 0.0021
445 THERAPY PARTIAL RESPONDER 32 0.0020
446 ORAL CANDIDIASIS 27 0.0020
447 NEPHROLITHIASIS 94 0.0020
448 PNEUMONIA ASPIRATION 51 0.0020
449 HOSPICE CARE 20 0.0020
450 RENAL IMPAIRMENT 170 0.0020
451 LARGE INTESTINE PERFORATION 14 0.0020
452 ORAL PAIN 45 0.0020
453 COLITIS 76 0.0020
454 LABORATORY TEST ABNORMAL 59 0.0020
455 PROTEINURIA 38 0.0020
456 GASTROENTERITIS VIRAL 36 0.0020
457 METASTASES TO LUNG 23 0.0020
458 PAPULE 14 0.0020
459 OEDEMA PERIPHERAL 242 0.0020
460 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
461 SKIN HYPERPIGMENTATION 17 0.0020
462 URINARY RETENTION 66 0.0020
463 EATING DISORDER 42 0.0020
464 PULMONARY CONGESTION 26 0.0020
465 ACIDOSIS 15 0.0020
466 HAEMATOCHEZIA 108 0.0020
467 FUNGAL INFECTION 65 0.0019
468 BLOOD CREATININE INCREASED 127 0.0019
469 THERAPY CHANGE 19 0.0019
470 ERYTHEMA MULTIFORME 18 0.0019
471 PELVIC FRACTURE 15 0.0019
472 EPISTAXIS 143 0.0019
473 BODY TEMPERATURE INCREASED 39 0.0019
474 PNEUMONITIS 52 0.0019
475 HAEMOLYTIC ANAEMIA 17 0.0019
476 PRURITUS GENERALISED 41 0.0019
477 DECREASED APPETITE 440 0.0019
478 ANAL INCONTINENCE 17 0.0019
479 DYSPNOEA EXERTIONAL 71 0.0019
480 METASTASES TO LIVER 33 0.0019
481 HAEMATOCRIT DECREASED 37 0.0019
482 PRODUCTIVE COUGH 89 0.0019
483 HYPERCALCAEMIA 23 0.0019
484 INTERNATIONAL NORMALISED RATIO INCREASED 53 0.0019
485 PEMPHIGOID 14 0.0019
486 GASTROINTESTINAL HAEMORRHAGE 155 0.0019
487 SCAB 21 0.0018
488 PLATELET COUNT INCREASED 24 0.0018
489 POOR VENOUS ACCESS 19 0.0018
490 HYPONATRAEMIA 103 0.0018
491 LIPASE INCREASED 14 0.0018
492 POST PROCEDURAL COMPLICATION 35 0.0018
493 BRAIN OEDEMA 23 0.0018
494 NOCTURIA 22 0.0018
495 MUSCULOSKELETAL CHEST PAIN 28 0.0018
496 FLUID RETENTION 92 0.0018
497 RED BLOOD CELL SEDIMENTATION RATE INCREASED 20 0.0018
498 MYELOSUPPRESSION 65 0.0018
499 HYPOPHAGIA 46 0.0018
500 LIVE BIRTH 15 0.0018
501 HAEMODIALYSIS 15 0.0018
502 INFUSION SITE PAIN 23 0.0018
503 WHITE BLOOD CELL COUNT DECREASED 193 0.0018
504 ORTHOSTATIC HYPOTENSION 31 0.0018
505 OSTEOPENIA 27 0.0018
506 CONSTIPATION 387 0.0018
507 OEDEMA 96 0.0018
508 LIP DRY 16 0.0018
509 STEVENS-JOHNSON SYNDROME 39 0.0018
510 ABDOMINAL PAIN UPPER 361 0.0018
511 DIARRHOEA 1130 0.0017
512 SUBDURAL HAEMATOMA 25 0.0017
513 ANURIA 15 0.0017
514 HYPERKALAEMIA 61 0.0017
515 HEPATITIS C 21 0.0017
516 FULL BLOOD COUNT DECREASED 35 0.0017
517 MYOPATHY 15 0.0017
518 DISEASE PROGRESSION 205 0.0017
519 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
520 PULMONARY OEDEMA 77 0.0017
521 POST PROCEDURAL HAEMORRHAGE 20 0.0017
522 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
523 RASH MACULO-PAPULAR 38 0.0017
524 ULCER 27 0.0017
525 SEASONAL ALLERGY 24 0.0017
526 FLATULENCE 96 0.0017
527 IMPAIRED GASTRIC EMPTYING 23 0.0017
528 INFLUENZA 188 0.0017
529 LUNG INFECTION 26 0.0017
530 CELLULITIS 84 0.0017
531 HAEMOGLOBIN DECREASED 171 0.0017
532 DEHYDRATION 222 0.0017
533 DRUG INTERACTION 264 0.0017
534 MYELODYSPLASTIC SYNDROME 24 0.0017
535 MULTIPLE ALLERGIES 13 0.0017
536 MUSCLE ATROPHY 21 0.0017
537 SKIN LACERATION 18 0.0017
538 GASTRIC HAEMORRHAGE 19 0.0016
539 SKIN LESION 45 0.0016
540 ORAL HERPES 32 0.0016
541 BLOOD POTASSIUM DECREASED 49 0.0016
542 ATRIAL FLUTTER 13 0.0016
543 RENAL FAILURE ACUTE 69 0.0016
544 EAR INFECTION 43 0.0016
545 INCONTINENCE 17 0.0016
546 BONE PAIN 94 0.0016
547 BLOOD CALCIUM INCREASED 14 0.0016
548 PHOTOPHOBIA 30 0.0016
549 METABOLIC ACIDOSIS 51 0.0016
550 LEUKAEMIA 15 0.0016
551 PANCREATITIS 84 0.0016
552 POLYURIA 13 0.0016
553 GASTROINTESTINAL DISORDER 142 0.0016
554 LUNG INFILTRATION 14 0.0016
555 HICCUPS 13 0.0016
556 RHABDOMYOLYSIS 66 0.0016
557 FEEDING DISORDER 32 0.0016
558 BONE MARROW FAILURE 32 0.0016
559 SPINAL COMPRESSION FRACTURE 13 0.0016
560 COVID-19 275 0.0016
561 MOUTH ULCERATION 33 0.0016
562 EMBOLISM 13 0.0016
563 SINUS DISORDER 31 0.0016
564 SHOCK 36 0.0016
565 NEURALGIA 38 0.0016
566 WEIGHT DECREASED 436 0.0016
567 ASPIRATION 17 0.0016
568 OXYGEN SATURATION DECREASED 87 0.0015
569 VASCULITIS 18 0.0015
570 CARDIOMEGALY 19 0.0015
571 C-REACTIVE PROTEIN INCREASED 56 0.0015
572 BLOOD SODIUM DECREASED 29 0.0015
573 PRODUCT AVAILABILITY ISSUE 35 0.0015
574 DENTAL CARIES 17 0.0015
575 RECTAL HAEMORRHAGE 66 0.0015
576 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
577 RENAL DISORDER 71 0.0015
578 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 73 0.0015
579 HAEMATURIA 52 0.0015
580 INTENTIONAL PRODUCT USE ISSUE 133 0.0015
581 SECRETION DISCHARGE 19 0.0015
582 BLOOD COUNT ABNORMAL 23 0.0015
583 CARDIAC FAILURE 121 0.0015
584 HYPOTENSION 302 0.0015
585 CARDIAC MURMUR 13 0.0015
586 HERNIA 29 0.0015
587 MIDDLE INSOMNIA 28 0.0015
588 PREGNANCY 30 0.0015
589 LYMPHADENOPATHY 53 0.0015
590 COUGH 419 0.0015
591 DRY EYE 74 0.0015
592 GENERAL PHYSICAL HEALTH DETERIORATION 171 0.0015
593 PULMONARY MASS 22 0.0015
594 BLOOD URINE PRESENT 28 0.0015
595 PERIPHERAL COLDNESS 20 0.0015
596 WEIGHT INCREASED 325 0.0014
597 LUNG DISORDER 71 0.0014
598 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
599 RESPIRATORY DISORDER 43 0.0014
600 URINARY TRACT INFECTION 245 0.0014
601 LUPUS-LIKE SYNDROME 13 0.0014
602 HAEMATOMA 37 0.0014
603 FISTULA 16 0.0014
604 BODY TEMPERATURE DECREASED 14 0.0014
605 DRUG WITHDRAWAL SYNDROME NEONATAL 21 0.0014
606 DEPRESSED LEVEL OF CONSCIOUSNESS 56 0.0014
607 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
608 INCREASED TENDENCY TO BRUISE 13 0.0014
609 IMMUNODEFICIENCY 21 0.0014
610 BLOOD GLUCOSE ABNORMAL 26 0.0014
611 FATIGUE 1095 0.0014
612 VOMITING 660 0.0014
613 GINGIVAL BLEEDING 19 0.0014
614 PHARYNGITIS STREPTOCOCCAL 15 0.0014
615 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
616 DELIRIUM 48 0.0014
617 SQUAMOUS CELL CARCINOMA 13 0.0014
618 OBESITY 22 0.0014
619 DRY MOUTH 112 0.0014
620 DIVERTICULITIS 38 0.0014
621 INITIAL INSOMNIA 14 0.0014
622 INCREASED APPETITE 26 0.0014
623 CHILLS 159 0.0014
624 PRODUCT DOSE OMISSION 88 0.0013
625 CONJUNCTIVITIS 25 0.0013
626 PRODUCT DOSE OMISSION ISSUE 396 0.0013
627 ERUCTATION 26 0.0013
628 BRAIN FOG 21 0.0013
629 OROPHARYNGEAL PAIN 124 0.0013
630 BLOOD PRESSURE DECREASED 89 0.0013
631 HYPERLIPIDAEMIA 16 0.0013
632 ASTHENIA 502 0.0013
633 BLOOD CALCIUM DECREASED 15 0.0013
634 HAEMORRHOIDS 26 0.0013
635 CONDITION AGGRAVATED 405 0.0013
636 GASTRITIS 35 0.0013
637 INFUSION RELATED REACTION 88 0.0013
638 REBOUND EFFECT 15 0.0013
639 HERPES ZOSTER 76 0.0013
640 RHINORRHOEA 85 0.0013
641 LIGAMENT SPRAIN 13 0.0013
642 EOSINOPHILIA 23 0.0013
643 HYPERTHYROIDISM 19 0.0013
644 RASH PRURITIC 71 0.0013
645 RESPIRATORY TRACT INFECTION 34 0.0013
646 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
647 UPPER RESPIRATORY TRACT INFECTION 60 0.0013
648 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
649 BLOOD PRESSURE FLUCTUATION 31 0.0013
650 IMMUNE SYSTEM DISORDER 17 0.0013
651 CONFUSIONAL STATE 208 0.0013
652 LETHARGY 74 0.0013
653 CARDIOMYOPATHY 19 0.0013
654 ANAPHYLACTIC REACTION 71 0.0013
655 DRUG RESISTANCE 33 0.0013
656 ABDOMINAL DISCOMFORT 215 0.0013
657 HYPERTENSION 271 0.0013
658 HALLUCINATION, VISUAL 27 0.0013
659 SLEEP DISORDER 90 0.0013
660 NEUROPATHY PERIPHERAL 121 0.0013
661 CYANOSIS 20 0.0013
662 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
663 NAUSEA 1004 0.0013
664 ATRIAL FIBRILLATION 123 0.0013
665 DISORIENTATION 50 0.0013
666 BLOOD PRESSURE INCREASED 191 0.0012
667 FACE OEDEMA 21 0.0012
668 HEAD DISCOMFORT 22 0.0012
669 ECZEMA 65 0.0012
670 OSTEOPOROSIS 51 0.0012
671 HIATUS HERNIA 16 0.0012
672 INTENTIONAL DOSE OMISSION 35 0.0012
673 CYSTITIS 39 0.0012
674 TREATMENT NONCOMPLIANCE 67 0.0012
675 DYSPEPSIA 120 0.0012
676 TACHYCARDIA 108 0.0012
677 HIP FRACTURE 39 0.0012
678 CARDIAC ARREST 100 0.0012
679 TOOTH EXTRACTION 15 0.0012
680 UPPER LIMB FRACTURE 24 0.0012
681 HAEMORRHAGE INTRACRANIAL 18 0.0012
682 ILLNESS 124 0.0012
683 PRESCRIBED UNDERDOSE 24 0.0012
684 PRODUCT USE IN UNAPPROVED INDICATION 298 0.0012
685 ALTERED STATE OF CONSCIOUSNESS 26 0.0012
686 DISEASE RECURRENCE 57 0.0012
687 DIALYSIS 17 0.0012
688 SPINAL FRACTURE 24 0.0012
689 PRESYNCOPE 29 0.0012
690 PULMONARY THROMBOSIS 13 0.0012
691 PRODUCT USE ISSUE 224 0.0012
692 CONTUSION 114 0.0012
693 HYPOGLYCAEMIA 57 0.0012
694 CHRONIC KIDNEY DISEASE 89 0.0012
695 ANAPHYLACTIC SHOCK 30 0.0012
696 PERIPHERAL SWELLING 179 0.0012
697 HAEMORRHAGE 121 0.0012
698 SKIN DISCOLOURATION 53 0.0012
699 RASH ERYTHEMATOUS 55 0.0011
700 ABDOMINAL PAIN LOWER 29 0.0011
701 CEREBRAL INFARCTION 28 0.0011
702 DIABETES MELLITUS 87 0.0011
703 DEVICE OCCLUSION 16 0.0011
704 PHARYNGITIS 14 0.0011
705 HEPATOCELLULAR INJURY 16 0.0011
706 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
707 CHEST DISCOMFORT 115 0.0011
708 CARDIOGENIC SHOCK 16 0.0011
709 NASOPHARYNGITIS 205 0.0011
710 DYSPHAGIA 105 0.0011
711 LEUKOCYTOSIS 20 0.0011
712 POLLAKIURIA 46 0.0011
713 COMPLICATION ASSOCIATED WITH DEVICE 16 0.0011
714 EJECTION FRACTION DECREASED 17 0.0011
715 BASAL CELL CARCINOMA 17 0.0011
716 INSOMNIA 290 0.0011
717 SKIN ULCER 28 0.0011
718 EAR PAIN 21 0.0011
719 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
720 COLD SWEAT 19 0.0011
721 APHONIA 15 0.0011
722 BRADYCARDIA 57 0.0011
723 MASS 15 0.0011
724 BLOOD CHOLESTEROL INCREASED 50 0.0011
725 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 25 0.0011
726 RASH 467 0.0011
727 CARPAL TUNNEL SYNDROME 15 0.0011
728 THROMBOSIS 86 0.0011
729 NO THERAPEUTIC RESPONSE 13 0.0011
730 CHEST PAIN 197 0.0011
731 PERITONITIS 22 0.0011
732 LYMPHOPENIA 15 0.0011
733 TOXICITY TO VARIOUS AGENTS 178 0.0011
734 SOMNOLENCE 211 0.0010
735 HYPERSOMNIA 30 0.0010
736 JOINT RANGE OF MOTION DECREASED 14 0.0010
737 ARTHRALGIA 433 0.0010
738 ANGIOEDEMA 46 0.0010
739 OSTEOARTHRITIS 44 0.0010
740 MALIGNANT NEOPLASM PROGRESSION 106 0.0010
741 MYALGIA 175 0.0010
742 HEART RATE DECREASED 36 0.0010
743 PAIN IN JAW 29 0.0010
744 LACTIC ACIDOSIS 33 0.0010
745 PRODUCT USE COMPLAINT 16 0.0010
746 BRONCHITIS 75 0.0010
747 HEART RATE INCREASED 100 0.0010
748 METASTASES TO CENTRAL NERVOUS SYSTEM 13 0.0010
749 NEOPLASM PROGRESSION 35 0.0010
750 DYSPNOEA 568 0.0010
751 GOUT 18 0.0010
752 CIRCULATORY COLLAPSE 17 0.0010
753 SINUSITIS 102 0.0010
754 SCAR 17 0.0010
755 LOCALISED INFECTION 24 0.0010
756 PALLOR 27 0.0010
757 DYSPHONIA 58 0.0010
758 HEADACHE 611 0.0010
759 DIZZINESS 485 0.0010
760 SURGERY 57 0.0010
761 FALL 323 0.0010
762 INFLAMMATION 50 0.0010
763 BACK PAIN 224 0.0010
764 DRUG INTOLERANCE 93 0.0010
765 SINUS CONGESTION 13 0.0010
766 BLOOD PRESSURE ABNORMAL 19 0.0010
767 DYSURIA 35 0.0009
768 MUSCULAR WEAKNESS 108 0.0009
769 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
770 TREMOR 157 0.0009
771 RESPIRATORY TRACT CONGESTION 15 0.0009
772 MALAISE 414 0.0009
773 LOWER LIMB FRACTURE 18 0.0009
774 BONE DISORDER 17 0.0009
775 DYSARTHRIA 35 0.0009
776 POOR QUALITY SLEEP 20 0.0009
777 ABORTION SPONTANEOUS 37 0.0009
778 CARDIAC FAILURE CONGESTIVE 74 0.0009
779 SKIN FISSURES 18 0.0009
780 TYPE 2 DIABETES MELLITUS 31 0.0009
781 LIMB INJURY 25 0.0009
782 LEUKOPENIA 46 0.0009
783 NASAL CONGESTION 54 0.0009
784 KIDNEY INFECTION 18 0.0009
785 PULMONARY EMBOLISM 87 0.0009
786 SEIZURE 105 0.0009
787 VENTRICULAR TACHYCARDIA 15 0.0009
788 RESPIRATORY ARREST 25 0.0009
789 LYMPHOMA 14 0.0009
790 FEMUR FRACTURE 28 0.0009
791 NIGHT SWEATS 29 0.0009
792 SYNCOPE 90 0.0009
793 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 161 0.0009
794 DYSSTASIA 26 0.0009
795 DEPRESSION 202 0.0009
796 ARRHYTHMIA 42 0.0009
797 EYE PAIN 50 0.0009
798 HEMIPARESIS 15 0.0009
799 DEEP VEIN THROMBOSIS 57 0.0009
800 RENAL INJURY 26 0.0009
801 PRODUCT PRESCRIBING ISSUE 19 0.0009
802 SKIN DISORDER 29 0.0009
803 ARTHRITIS 68 0.0009
804 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
805 DEMENTIA 24 0.0009
806 ADVERSE DRUG REACTION 77 0.0009
807 HEAD INJURY 27 0.0009
808 METASTASES TO BONE 14 0.0009
809 MANIA 14 0.0009
810 ANXIETY 242 0.0008
811 RASH PAPULAR 19 0.0008
812 DIPLOPIA 22 0.0008
813 RETCHING 18 0.0008
814 FOOT FRACTURE 16 0.0008
815 PSYCHOMOTOR HYPERACTIVITY 14 0.0008
816 SPEECH DISORDER 44 0.0008
817 IRRITABLE BOWEL SYNDROME 18 0.0008
818 BALANCE DISORDER 72 0.0008
819 HEPATIC CANCER 20 0.0008
820 PROCEDURAL PAIN 23 0.0008
821 OSTEOMYELITIS 15 0.0008
822 RIB FRACTURE 17 0.0008
823 RESTLESSNESS 30 0.0008
824 DEATH 706 0.0008
825 EPILEPSY 25 0.0008
826 ABSCESS 13 0.0008
827 ASTHMA 92 0.0008
828 ALOPECIA 159 0.0008
829 GAIT INABILITY 27 0.0008
830 LOSS OF CONSCIOUSNESS 103 0.0008
831 NERVOUS SYSTEM DISORDER 25 0.0008
832 PAIN IN EXTREMITY 235 0.0008
833 APHASIA 24 0.0008
834 PALPITATIONS 93 0.0008
835 ILL-DEFINED DISORDER 48 0.0008
836 SKIN CANCER 17 0.0008
837 CATARACT 47 0.0008
838 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
839 PERICARDITIS 13 0.0008
840 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 55 0.0008
841 CRYING 28 0.0008
842 DERMATITIS 16 0.0008
843 AGEUSIA 19 0.0008
844 MUSCLE SPASMS 139 0.0008
845 DRY SKIN 101 0.0008
846 MUSCULOSKELETAL DISCOMFORT 13 0.0008
847 AMNESIA 49 0.0008
848 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
849 FLUSHING 76 0.0007
850 EYE PRURITUS 25 0.0007
851 MEMORY IMPAIRMENT 102 0.0007
852 MUSCLE TWITCHING 17 0.0007
853 TREATMENT FAILURE 61 0.0007
854 THROAT IRRITATION 33 0.0007
855 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
856 SLEEP APNOEA SYNDROME 14 0.0007
857 BLOOD GLUCOSE DECREASED 35 0.0007
858 DRUG INEFFECTIVE 959 0.0007
859 LOWER RESPIRATORY TRACT INFECTION 33 0.0007
860 VERTIGO 44 0.0007
861 DEPRESSED MOOD 38 0.0007
862 WOUND 20 0.0007
863 PAIN 439 0.0007
864 FEELING ABNORMAL 171 0.0007
865 WHEEZING 42 0.0007
866 HEART RATE IRREGULAR 16 0.0007
867 AGITATION 52 0.0007
868 GAIT DISTURBANCE 135 0.0007
869 THROAT TIGHTNESS 19 0.0007
870 GASTRIC DISORDER 24 0.0007
871 URTICARIA 117 0.0007
872 JOINT STIFFNESS 18 0.0007
873 SWELLING 64 0.0007
874 DRUG DOSE OMISSION 113 0.0007
875 FEELING COLD 19 0.0007
876 FEELING JITTERY 13 0.0007
877 ERYTHEMA 140 0.0007
878 HYPERSENSITIVITY 126 0.0007
879 ACUTE MYOCARDIAL INFARCTION 20 0.0007
880 EYE IRRITATION 39 0.0007
881 UNDERDOSE 49 0.0007
882 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
883 CARDIO-RESPIRATORY ARREST 28 0.0007
884 FEELING HOT 41 0.0007
885 MENTAL DISORDER 29 0.0007
886 MUSCULOSKELETAL STIFFNESS 58 0.0007
887 UNEVALUABLE EVENT 50 0.0007
888 MENTAL IMPAIRMENT 16 0.0007
889 NEOPLASM MALIGNANT 44 0.0007
890 BLISTER 37 0.0007
891 RASH MACULAR 23 0.0007
892 INJECTION SITE PRURITUS 44 0.0007
893 ACCIDENTAL OVERDOSE 24 0.0007
894 JOINT INJURY 14 0.0007
895 JOINT SWELLING 79 0.0007
896 TINNITUS 30 0.0007
897 COMA 31 0.0007
898 ANGER 22 0.0006
899 DEAFNESS 17 0.0006
900 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
901 CONVULSION 37 0.0006
902 SWELLING FACE 42 0.0006
903 NECK PAIN 36 0.0006
904 THERAPEUTIC RESPONSE DECREASED 39 0.0006
905 URINARY INCONTINENCE 19 0.0006
906 DISCOMFORT 39 0.0006
907 ABNORMAL BEHAVIOUR 25 0.0006
908 VISUAL IMPAIRMENT 78 0.0006
909 MOOD SWINGS 20 0.0006
910 HALLUCINATION 47 0.0006
911 MOOD ALTERED 17 0.0006
912 INFLUENZA LIKE ILLNESS 51 0.0006
913 FIBROMYALGIA 15 0.0006
914 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
915 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
916 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
917 MOBILITY DECREASED 43 0.0006
918 LACRIMATION INCREASED 18 0.0006
919 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
920 HYPOAESTHESIA 89 0.0006
921 BLOOD GLUCOSE INCREASED 112 0.0006
922 MUSCULOSKELETAL PAIN 31 0.0006
923 PLASMA CELL MYELOMA 23 0.0006
924 MIGRAINE 56 0.0006
925 UNRESPONSIVE TO STIMULI 15 0.0006
926 HYPOACUSIS 25 0.0006
927 IMPAIRED HEALING 19 0.0006
928 NERVOUSNESS 30 0.0006
929 LIP SWELLING 19 0.0006
930 COGNITIVE DISORDER 26 0.0006
931 PANIC ATTACK 20 0.0005
932 BLINDNESS 22 0.0005
933 VISION BLURRED 74 0.0005
934 DISTURBANCE IN ATTENTION 29 0.0005
935 DRUG EXPOSURE DURING PREGNANCY 18 0.0005
936 BURNING SENSATION 37 0.0005
937 ANGINA PECTORIS 15 0.0005
938 RHEUMATOID ARTHRITIS 59 0.0005
939 VISUAL ACUITY REDUCED 17 0.0005
940 SKIN EXFOLIATION 43 0.0005
941 HYPERHIDROSIS 65 0.0005
942 PARAESTHESIA 78 0.0005
943 EYE DISORDER 16 0.0005
944 OCULAR HYPERAEMIA 23 0.0005
945 AGGRESSION 24 0.0005
946 ROAD TRAFFIC ACCIDENT 20 0.0005
947 ADVERSE EVENT 44 0.0005
948 CARDIAC DISORDER 44 0.0005
949 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
950 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
951 ACNE 35 0.0005
952 VAGINAL HAEMORRHAGE 20 0.0005
953 CEREBROVASCULAR ACCIDENT 78 0.0005
954 DYSGEUSIA 34 0.0005
955 EYE SWELLING 17 0.0005
956 LIMB DISCOMFORT 14 0.0005
957 INJURY 31 0.0004
958 MOVEMENT DISORDER 14 0.0004
959 MYOCARDIAL INFARCTION 76 0.0004
960 INJECTION SITE ERYTHEMA 54 0.0004
961 INTENTIONAL PRODUCT MISUSE 37 0.0004
962 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
963 IRRITABILITY 25 0.0004
964 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
965 MEDICATION ERROR 23 0.0004
966 INJECTION SITE MASS 15 0.0004
967 HOT FLUSH 30 0.0004
968 OSTEONECROSIS 13 0.0004
969 INJECTION SITE HAEMORRHAGE 30 0.0004
970 SUICIDAL IDEATION 34 0.0004
971 INCORRECT DOSE ADMINISTERED 84 0.0004
972 DERMATITIS ATOPIC 19 0.0004
973 PSORIASIS 47 0.0004
974 DEVICE MALFUNCTION 24 0.0003
975 LUNG NEOPLASM MALIGNANT 14 0.0003
976 INJECTION SITE PAIN 103 0.0003
977 PSORIATIC ARTHROPATHY 13 0.0003
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 64 0.0003
979 INJECTION SITE BRUISING 25 0.0003
980 PRODUCT SUBSTITUTION ISSUE 18 0.0003
981 ARTHROPATHY 17 0.0003
982 NO ADVERSE EVENT 54 0.0003
983 DRUG EFFECT DECREASED 16 0.0003
984 EMOTIONAL DISTRESS 30 0.0002
985 INJECTION SITE REACTION 17 0.0002
986 OVERDOSE 53 0.0002
987 INJECTION SITE SWELLING 18 0.0002
988 SKIN BURNING SENSATION 16 0.0002
989 DEVICE ISSUE 20 0.0002
990 PRODUCT QUALITY ISSUE 28 0.0002
991 PROSTATE CANCER 14 0.0002
992 BREAST CANCER 15 0.0002
993 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002